Close Lucintel Chat
Didn't Find What You're Looking for?
Call us at +1972 636 5056 or write at helpdesk@Lucintel.com
Ask an Expert Provide Custom Requirements Download Sample Report Search Available Reports
  • helpdesk@Lucintel.com
  • |
  • Call Lucintel +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |
'
...

Request the impact of COVID-19 in this market at no additional cost. Buy it today to get an advantage.

Request Now


The global retail drug industry has grown steadily over the last five years and is expected to reach approximately US $1,420 billion in 2017 with a CAGR of 3.6% over the next five years. Direct mail advertising, television and print media advertising, telemarketing, Internet advertising and social media, as well as bundled product

and service strategies, are expected to drive industry growth.

Lucintel, a leading global management consulting and market research firm, has conducted a competitive analysis of the global retail drug companies and presents its findings in “Top Five Global Retail Drug Companies: Performance, Strategies, and Competitive Analysis.” The report provides detailed insight into the performance of the top five global retail drug companies across the world. The analysis highlights the companies that are performing the best among the peer group, and in which areas, and therefore clarifies leading performance standards and the strengths and weaknesses of companies covered.

The retail drug industry is highly diversified and includes pharmacies and drug stores, cosmetics, beauty supplies, and perfume stores, optical goods stores, other health, and personal care stores. In this study, Lucintel thoroughly profiles the following five companies with detailed competitive assessments:
 
  • CVS Caremark    
  • Rite Aid        
  • Target Corp.          
  • Walgreens             
  • Walmart                   
Lucintel’s research indicates that the Asia Pacific (APAC) region depicts the best growth prospects for retailers with its increasing aging population, greater health consciousness, and consumer demand. The macroeconomic factors such as rising population and increasing disposable income of consumers are anticipated to impact market dynamics significantly. Strategic product alliances directly with industry-leading manufacturers also can help raise sales in this industry.

This study is intended to provide industry leaders with a competitive benchmarking of the world’s top five global retail drug companies. The study provides up-to-date information on the market share, profit margins, capabilities, and strategies of the leaders. The report helps current suppliers realistically assess their strengths vis-a-vis leading competitors. It is designed to provide executives with strategically significant competitor information, data analysis, and insight critical to the development and implementation of effective marketing and sales plans.

Retail drug competitive analysis report will save hundreds of hours of your own personal research time and will significantly benefit you in expanding your business opportunities in global retail drug companies industry. In today’s chaotic economy, you need every advantage that you can find to keep ahead in your business

In Lucintel's newest competitive research study on the world's retail drug companies, we thoroughly profile following five companies with detailed competitive assessments:
 
  • CVS Caremark    
  • Rite Aid        
  • Target Corp.          
  • Walgreens             
  • Walmart

The detailed analysis of each company offers a critical view into key strategic areas, including:
 
  • Company overview          
  • Benchmarking (financial & market)
  • SWOT analysis         
  • Product positioning
  • Marketing strategy and tactics    
  • Corporate strategy
To make any investment, business or strategic decisions, you need adequate and timely information.Retail drug competitive analysis market report fulfills this core need. This is an indispensable reference guide for industry executives who are dealing with retail drug companies industry. 

Some of the features of Top Five Global Retail Drug Companies: Performance, Strategies, and Competitive Analysis market intelligence report are:
 
  • Market size estimates in terms of (US $) value by segments of the global retail drug companies
  • Regional analysis: global retail drug companies breakdown by key regions (e.g., North America, Europe, APAC and ROW)
  • Retail drug competitive analysis market trends, drivers and forecasts
  • Competitive benchmarking of each players against their financial & market strength
  • Global and regional market share estimates for the top players
  • Product line overview and positioning of top players
  • SWOT analysis of the leaders
  • Marketing strategy and tactics    
  • Corporate strategy
  • More than 113 valuable figures/charts and 45 tables are provided in this report
 
 1. Executive Summary  

 2. Market Definition and Scope  

 3. Market Opportunity  

 4. Competitive Benchmarking (Financial and Market)  

 5. Company Profile on Following Parameters  

 6. Profiles on Following Companies  
 6.1. CVS Caremark  
 6.2. Rite Aid  
 6.3. Target Corp  
 6.4. Walgreens  
 6.5. Walmart  

List of Figures
 
CHAPTER 3. Market Opportunity
Figure 3.1: Supply chain for retail drug market
Figure 3.2: Global retail drug industry annual trend 2006-2011 (US $B)
Figure 3.3: Global retail drug industry regional trend 2006-2011 (US $B)
Figure 3.4: Global retail drug industry regional trend 2006-2011 (%)
Figure 3.5: Global retail drug industry segment trend 2006-2011 (US $B)
Figure 3.6: Global retail drug industry segment trend 2006-2011 (%)
Figure 3.7: Global retail drug industry opportunity by region
Figure 3.8: Global retail drug industry opportunity by segment
    
CHAPTER 4. Competitive Benchmarking (Financial and Market)
Figure 4.1: Top five retail drug companies – financial benchmarking
Figure 4.2: Global top five retail drug companies gross profit and net profit analysis – 2011
Figure 4.3: Financial analysis – growth leadership quadrant (2011)
Figure 4.4: Market share of top players 2006
Figure 4.5: Market share of top players 2011
Figure 4.6: 2006 Market share analysis 2011
Figure 4.7: 2011 Market share analysis 2011
Figure 4.8: Global market share analysis 2011
Figure 4.9: Global market fragmentation 2011  
Figure 4.10: Market value North America: (US $B)
Figure 4.11: Market value Europe: (US $B)
Figure 4.12: Market value Asia Pacific: (US $B)
Figure 4.13: Market value Row: (US $B)
Figure 4.14: Regional revenue evaluation 2011(US $B)
Figure 4.15: Regional revenue evaluation 2011(%)
Figure 4.16: North American revenue trend for top players 2007-2011 (US $B)
Figure 4.17: Europe revenue trend for top players 2007-2011 (US $B)
Figure 4.18: Asia Pacific revenue trend for top players 2007-2011 (US $B)
Figure 4.19: Row revenue trend for top players 2007-2011 (US $B)
Figure 4.20: Lucintel triad - top five major players
 
CHAPTER 5. Company Profile of CVS Caremark
Figure 5.1: CVS Caremark’s revenue by business structure 2011
Figure 5.2: Lucintel Triad – CVS Caremark’s
Figure 5.3: Financial benchmarking CVS Caremark’s against top three and top five industry players’ average
Figure 5.4: Financial benchmarking of CVS Caremark’s against top five best
Figure 5.5: Global industry revenue trend Vs CVS Caremark’s (2007-2011) in US $B
Figure 5.6: Global market share trend for CVS Caremark’s (2007-2011) in (%)
Figure 5.7: North American industry revenue trend Vs CVS Caremark’s 2007-2011 in (US $B)
Figure 5.8: European industry revenue trend Vs CVS Caremark’s 2007-2011 in (US $B)
Figure 5.9:   APAC industry revenue trend Vs CVS Caremark’s 2007-2011 in (US $B)
Figure 5.10: ROW industry revenue trend Vs CVS Caremark’s 2007-2011 in (US $B)
Figure 5.11: North American market share trend Vs CVS Caremark’s 2007-2011 in (%)
Figure 5.12: European market share trend Vs CVS Caremark’s 2007-2011 in (%)
Figure 5.13: APAC market share trend Vs CVS Caremark’s 2007-2011 in (%)
Figure 5.14: ROW market share trend Vs CVS Caremark’s 2007-2011 in (%)
Figure 5.15: CVS Caremark’s productivity: 2007-2011 in (US $B)
Figure 5.16: CVS Caremark’s fixed asset value: 2007-2011 in (US $B)
Figure 5.17: Strategic execution
 
CHAPTER 6. Company Profile of Rite Aid
Figure 6.1: Rite Aid revenue by business structure 2011
Figure 6.2: Lucintel triad - Rite Aid
Figure 6.3: Financial benchmarking of Rite Aid against top three and top five industry players’ average
Figure 6.4: Financial benchmarking of Rite Aid against Top five best
Figure 6.5: Global industry revenue trend Vs Rite Aid (2007-2011) in (US $B)
Figure 6.6: Global market share trend for Rite Aid. (2007-2011) in (%)
Figure 6.7: North American industry revenue trend Vs Rite Aid. 2007-2011 in (US $B)
Figure 6.8: European industry revenue trend Vs Rite Aid. 2007-2011 in (US $B)
Figure 6.9: APAC industry revenue trend Vs Rite Aid. 2007-2011 in (US $B)
Figure 6.10: ROW industry revenue trend Vs Rite Aid 2007-2011 in (US $B)
Figure 6.11: North American market share trend Vs Rite Aid. 2007-2011 in (%)
Figure 6.12: European market share trend Vs Rite Aid. 2007-2011 in (%)
Figure 6.13: APAC market share trend Vs Rite Aid. 2007-2011 in (%)
Figure 6.14: ROW market share trend Vs Rite Aid. 2007-2011 in (%)
Figure 6.15: Rite Aid productivity: 2007-2011 in (US $B)
Figure 6.16: Rite Aid fixed asset value: 2007-2011 in (US $B)
Figure 6.17: Strategic execution
 
CHAPTER 7. Company Profile of Target Corp.  
Figure 7.1: Target Corp. revenue by business structure 2011
Figure 7.2: Lucintel triad – Target Corp.
Figure 7.3: Financial benchmarking of Target Corp. against top three and top five industry players’ average
Figure 7.4: Financial benchmarking of Target Corp. against Top five best
Figure 7.5: Global industry revenue trend Vs Target Corp. (2007-2011) in (US $B)
Figure 7.6: Global market share trend for Target Corp. (2007-2011) in (%)
Figure 7.7: North American industry revenue trend Vs Target Corp. (2007-2011) in (US $B)
Figure 7.8: European industry revenue trend Vs Target Corp. (2007-2011) in (US $B)
Figure 7.9: APAC industry revenue trend Vs Target Corp. (2007-2011) in (US $B)
Figure 7.10: ROW industry revenue trend Vs Target Corp. (2007-2011) in (US $B)
Figure 7.11: North American market share trend Vs Target Corp. (2007-2011) in (%)
Figure 7.12: European market share trend Vs Target Corp. (2007-2011) in (%)
Figure 7.13: APAC market share trend Vs Target Corp. (2007-2011) in (%)
Figure 7.14: ROW market share trend Vs Target Corp. (2007-2011) in (%)
Figure 7.15: Target Corp. productivity: 2007-2011 in (US $B)
Figure 7.16: Target Corp. fixed asset value: 2007-2011 in (US $B)
Figure 7.17: Strategic execution
 
CHAPTER 8. Company Profile of Walgreens
Figure 8.1: Walgreens revenue by business structure 2011
Figure 8.2: Lucintel triad – Walgreens
Figure 8.3: Financial benchmarking of Walgreens against top three and top five industry players’ average
Figure 8.4: Financial benchmarking of Walgreens against Top five best
Figure 8.5: Global industry revenue trend Vs Walgreens (2007-2011) in (US $B)
Figure 8.6: Global market share trend for Walgreens (2007-2011) in (%)
Figure 8.7: North American industry revenue trend Vs Walgreens (2007-2011) in (US $B)
Figure 8.8: European industry revenue trend
.

Buy full report or by chapter as follows

Price by License Type:
[-] Hide Chapter Details
[Chapter Number] [Chapter Name] [Chapter Number Of Pages] [Chapter Price]
Title/Chapter Name Pages Price
Full Report: Top Five Global Retail Drug Companies: Performance, Strategies, and Competitive Analysis, Full Report $ 1,980
More than 48 valuable figures/charts and 11 tables are provided in this report
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
  • In-depth interviews of the major players in this market
  • Detailed secondary research from competitors’ financial statements and published data 
  • Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
  • A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
 
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.